Prevalence, correlates, and viral dynamics of hepatitis delta among injection drug users.
about
Hepatitis delta virus: Making the point from virus isolation up to 2014Therapeutic Strategies and New Intervention Points in Chronic Hepatitis Delta Virus InfectionHepatitis delta: epidemiology, diagnosis and management 36 years after discoveryHepatitis D Virus: Introduction and EpidemiologyDelta hepatitis within the Veterans Affairs medical system in the United States: Prevalence, risk factors, and outcomes.Hepatitis D Virus: A Call to Screening.Coinfection with hepatitis B and D: epidemiology, prevalence and disease in patients in Northern California.Treatment options for hepatitis delta virus infection.Prevalence of hepatitis delta infection in the United States: National Health and Nutrition Examination Survey, 1999-2012.Hepatitis B, C, and D virus infection showing distinct patterns between injection drug users and the general population.Recommendations for the management of hepatitis C virus infection among people who inject drugs.Liver transplantation in a patient with hepatitis B, C and D coinfection associated with hepatocellular carcinoma: a management strategy for a rare condition. Case report.Changing hepatitis D virus epidemiology in a hepatitis B virus endemic area with a national vaccination program.Hepatitis delta is a major determinant of liver decompensation events and death in HIV-infected patients.Hepatitis D virus in Victoria 2000-2009.Recommendations for the management of hepatitis C virus infection among people who inject drugs.Chronic hepatitis D at a standstill: where do we go from here?
P2860
Q26783367-9C90D7B5-0841-406F-BCDF-1EEC26B52B46Q26795919-1B67F609-0F23-4C51-B155-763FE7524A5AQ26849602-3F3BE3D0-289B-4409-8671-06260CF3EE62Q35795551-540EA55D-A911-4564-9C6D-2F3F149D507EQ36072747-4526C099-3914-4F28-877E-450510274AFEQ37182821-B0E91CE4-AA45-4F9B-AC41-845EAF876AD8Q38097881-665B4439-9E78-4C73-9636-2C6C0556604AQ39502937-7123109D-9CFB-4AC9-99A8-D68E86645245Q40006324-2BC46A33-31BB-431B-9097-3C70CF1A52B8Q40650369-345DDFD6-EE8D-42B1-8A60-6737E24D5AE1Q41047662-4AEF1A2B-EF96-4D6E-BBE7-0457BD246F3AQ41107378-9E4B74BF-F6C6-407C-817B-378C62F7C72FQ41441778-422FC5DE-D31A-49F8-B70E-C6EFEC95E709Q42223767-72F5A90C-9014-46E1-BCE5-386D85A8BD46Q42254477-105E5F81-E930-4460-A367-755DCE2FFFFDQ42280296-A6120AAE-E9FD-4924-8AAA-EBCCA1F90745Q43492653-51818EEB-7729-47AB-A5F2-DA826B991359
P2860
Prevalence, correlates, and viral dynamics of hepatitis delta among injection drug users.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Prevalence, correlates, and viral dynamics of hepatitis delta among injection drug users.
@ast
Prevalence, correlates, and viral dynamics of hepatitis delta among injection drug users.
@en
type
label
Prevalence, correlates, and viral dynamics of hepatitis delta among injection drug users.
@ast
Prevalence, correlates, and viral dynamics of hepatitis delta among injection drug users.
@en
prefLabel
Prevalence, correlates, and viral dynamics of hepatitis delta among injection drug users.
@ast
Prevalence, correlates, and viral dynamics of hepatitis delta among injection drug users.
@en
P2093
P2860
P356
P1476
Prevalence, correlates, and viral dynamics of hepatitis delta among injection drug users.
@en
P2093
Dorry L Segev
Elizabeth T Golub
Gregory D Kirk
Homayoon Farzadegan
Jeffrey S Glenn
Jordan J Feld
Kenrad E Nelson
Lauren M Kucirka
Mark Winters
Morgan Marks
P2860
P304
P356
10.1086/655808
P407
P577
2010-09-01T00:00:00Z